Relief Balm

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

ZEN is indicated for the relief of aches and pains associated with various conditions. This all-natural relief balm, formulated with coconut oil, is specifically designed to provide symptomatic relief for the following conditions:

• Aches and pains related to rheumatoid arthritis

• Joint pain

• Backaches

• Bursitis

• Sore muscles

• Arthritis

• Leg cramps

• Sprains and strains

There are no teratogenic or nonteratogenic effects associated with ZEN.

Dosage and Administration

Healthcare professionals are advised to instruct patients to use the medication only as directed. The recommended application is to apply a generous amount to the affected area three to four times daily.

For pediatric patients under the age of 12, it is essential to consult a physician prior to use to ensure safety and appropriateness of treatment.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion. In the event of ingestion, immediate medical assistance or contact with a poison control center is required.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to discontinue use if excessive skin irritation develops. It is crucial to avoid contact with the eyes and mucous membranes, as this may lead to adverse effects. Additionally, patients should be instructed not to bandage the area tightly and to refrain from using the product in conjunction with a heating pad, as this may exacerbate irritation or cause other complications.

Patients should be closely monitored for any worsening of their condition or persistence of symptoms beyond 7 days. If symptoms resolve and then recur within a few days, or if excessive skin irritation occurs, patients are advised to stop use and consult a healthcare provider for further evaluation.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a poison control center without delay. Prompt action is essential to ensure patient safety and mitigate potential risks associated with the ingestion of this product.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event of excessive irritation of the skin, it is advised to discontinue use immediately. Care should be taken to avoid contact with the eyes and mucous membranes, as this may lead to adverse reactions. Additionally, patients should not bandage the area tightly or use the product in conjunction with a heating pad, as these practices may exacerbate potential side effects.

Patients are encouraged to stop use and consult a healthcare professional if their condition worsens or if symptoms persist for more than seven days. If symptoms initially clear up but then recur within a few days, it is also recommended to seek medical advice. Furthermore, any occurrence of excessive skin irritation should prompt immediate consultation with a healthcare provider.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Relief Balm (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, immediate medical assistance or contact with a poison control center is advised. For children under the age of 12, it is recommended to consult a healthcare professional prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The product has not been evaluated for safety during pregnancy. As such, there is limited information available regarding potential risks to the fetus. While no specific contraindications are mentioned, caution is advised due to the product's designation for external use only. There are no dosage modifications recommended for pregnant individuals, and no special precautions have been outlined for use during pregnancy. Healthcare professionals should consider the lack of safety data and weigh the potential benefits against any unknown risks when advising pregnant patients or women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with reduced kidney function, as the absence of specific guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide the management of the patient and to determine the most appropriate interventions.

Overall, vigilance and prompt action are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with ingestion by children.

In the event that the medication is swallowed, healthcare providers should instruct patients to seek medical help or contact a poison control center immediately. This prompt action is crucial for ensuring the safety and well-being of the patient.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light to prevent degradation. After opening, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application of a generous amount to the affected area 3 to 4 times daily. Clinicians should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event of swallowing, patients should seek medical assistance or contact a poison control center immediately. Additionally, it is important for patients to consult a doctor before use if they are under 12 years of age.

Drug Information (PDF)

This file contains official product information for Relief Balm, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)